Loading…
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Published in Diabetes care (01.03.2009)
Published in Diabetes care (01.03.2009)
Get full text
Journal Article
Loading…
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186
Gerber, John G, Kitch, Douglas W, Fichtenbaum, Carl J, Zackin, Robert A, Charles, Stéphannie, Hogg, Evelyn, Acosta, Edward P, Connick, Elizabeth, Wohl, David, Kojic, E Milu, Benson, Constance A, Aberg, Judith A
Published in Journal of acquired immune deficiency syndromes (1999) (01.04.2008)
Published in Journal of acquired immune deficiency syndromes (1999) (01.04.2008)
Get more information
Journal Article
Loading…
Loading…
The effect of simvastatin-fenofibrate combination therapy on endothelial function in the subjects with metabolic syndrome
Janczura, Mirosław, Rosa, Rafał, Dropinski, Jerzy, Kotula-Horowitz, Katarzyna, Stanisz, Andrzej, Domagała, Teresa
Published in Atherosclerosis (01.08.2024)
Published in Atherosclerosis (01.08.2024)
Get full text
Journal Article
Loading…
Reversibility of Fenofibrate Therapy–Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants
Mychaleckyj, Josyf C., Craven, Timothy, Nayak, Uma, Buse, John, Crouse, John R., Elam, Marshall, Kirchner, Kent, Lorber, Daniel, Marcovina, Santica, Sivitz, William, Sperl-Hillen, JoAnn, Bonds, Denise E., Ginsberg, Henry N.
Published in Diabetes care (01.05.2012)
Published in Diabetes care (01.05.2012)
Get full text
Journal Article
Loading…
1873-LB: Genetically Determined PPARA Expression Modulates Fenofibrate Response on Lipid Profile—A Pharmacogenetic Trial
MORIERI, MARIO LUCA, GIORDANO, MARTINA, FAGARAZZI, CARLO, BOSCARO, CARLOTTA, MARASSI, MARELLA, IORI, ELISABETTA, AMENDOLAGINE, FRANCESCO IVAN, RODELLA, ANNA, MIGLIOZZI, LUDOVICA, PIPINO, CATERINA, ZAMBON, CARLO FEDERICO, DORIA, ALESSANDRO, ALBIERO, MATTIA, FADINI, GIAN PAOLO
Published in Diabetes (New York, N.Y.) (20.06.2025)
Published in Diabetes (New York, N.Y.) (20.06.2025)
Get full text
Journal Article
Loading…
Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes
Ong, Kwok Leung, Rye, Kerry-Anne, O'Connell, Rachel, Jenkins, Alicia J., Brown, Chris, Xu, Aimin, Sullivan, David R., Barter, Philip J., Keech, Anthony C.
Published in The journal of clinical endocrinology and metabolism (01.12.2012)
Published in The journal of clinical endocrinology and metabolism (01.12.2012)
Get full text
Journal Article
Loading…
Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease
Fabbrini, Elisa, Mohammed, B. Selma, Korenblat, Kevin M., Magkos, Faidon, McCrea, Jennifer, Patterson, Bruce W., Klein, Samuel
Published in The journal of clinical endocrinology and metabolism (01.06.2010)
Published in The journal of clinical endocrinology and metabolism (01.06.2010)
Get full text
Journal Article
Loading…
Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models
Mahmoudi, Ali, Moallem, Seyed Adel, Johnston, Thomas P., Sahebkar, Amirhossein
Published in PPAR research (17.06.2022)
Published in PPAR research (17.06.2022)
Get full text
Journal Article
Loading…
Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants: The GOLDN Study
Lai, Chao-Qiang, Arnett, Donna K., Corella, Dolores, Straka, Robert J., Tsai, Michael Y., Peacock, James M., Adiconis, Xian, Parnell, Laurence D., Hixson, James E., Province, Michael A., Ordovas, Jose M.
Published in Arteriosclerosis, thrombosis, and vascular biology (01.06.2007)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.06.2007)
Get full text
Journal Article
Loading…
Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome
Rosenson, Robert S, Wolff, David A, Huskin, Anna L, Helenowski, Irene B, Rademaker, Alfred W
Published in Diabetes care (01.08.2007)
Published in Diabetes care (01.08.2007)
Get full text
Journal Article
Loading…
Hemodynamic Effects of Fenofibrate and Coenzyme Q₁₀ in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction
Chew, Gerard T, Watts, Gerald F, Davis, Timothy M.E, Stuckey, Bronwyn G.A, Beilin, Lawrence J, Thompson, Peter L, Burke, Valerie, Currie, Philip J
Published in Diabetes care (01.08.2008)
Published in Diabetes care (01.08.2008)
Get full text
Journal Article
Loading…
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes
Rotroff, Daniel M, Pijut, Sonja S, Marvel, Skylar W, Jack, John R, Havener, Tammy M, Pujol, Aurora, Schluter, Agatha, Graf, Gregory A, Ginsberg, Henry N, Shah, Hetal S, Gao, He, Morieri, Mario-Luca, Doria, Alessandro, Mychaleckyi, Josyf C, McLeod, Howard L, Buse, John B, Wagner, Michael J, Motsinger-Reif, Alison A
Published in Clinical pharmacology and therapeutics (01.04.2018)
Published in Clinical pharmacology and therapeutics (01.04.2018)
Get more information
Journal Article
Loading…
321-OR: Haptoglobin (Hp) Levels and Phenotype Are Unrelated to Severe Retinopathy in Type 2 Diabetes, but Lower Hp Reductions by Fenofibrate Are Associated with Greater Retinopathy Benefit—A FIELD Trial Study
LEUNG ONG, KWOK, JANUSZEWSKI, ANDRZEJ S., FRANCIS, HABIB, MANGANI, ABUBAKAR SIDDIQ O., O'CONNELL, RACHEL L., JENKINS, ALICIA, KEECH, ANTHONY C.
Published in Diabetes (New York, N.Y.) (14.06.2024)
Published in Diabetes (New York, N.Y.) (14.06.2024)
Get full text
Journal Article
Loading…
Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone
Ronsein, Graziella E., Reyes-Soffer, Gissette, He, Yi, Oda, Michael, Ginsberg, Henry, Heinecke, Jay W.
Published in Molecular & cellular proteomics (01.03.2016)
Published in Molecular & cellular proteomics (01.03.2016)
Get full text
Journal Article
Loading…
Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate
Dandan, Mohamad, Han, Julia, Mann, Sabrina, Kim, Rachael, Li, Kelvin, Mohammed, Hussein, Chuang, Jen-Chieh, Zhu, Kaiyi, Billin, Andrew N., Huss, Ryan S., Chung, Chuhan, Myers, Robert P., Hellerstein, Marc
Published in Journal of lipid research (01.03.2023)
Published in Journal of lipid research (01.03.2023)
Get full text
Journal Article
Loading…
Pharmacokinetics and bioequivalence of two fenofibrate choline formulations in healthy subjects under fed and fasted condition
Park, Ji-Min, Chae, Soo-In, Noh, Young Su, Lee, Seung-Jun, Shim, Wang-Seob, Yoon, Ji-Min, Hwang, Se Jung, Lee, Kyung-Tae, Chung, Eun Kyoung
Published in International journal of clinical pharmacology and therapeutics (01.04.2019)
Published in International journal of clinical pharmacology and therapeutics (01.04.2019)
Get full text
Journal Article
Loading…
Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome
Watts, Gerald F., Barrett, P. Hugh R., Ji, Juying, Serone, Adrian P., Chan, Dick C., Croft, Kevin D., Loehrer, Franziska, Johnson, Anthony G.
Published in Diabetes (New York, N.Y.) (01.03.2003)
Published in Diabetes (New York, N.Y.) (01.03.2003)
Get full text
Journal Article
Loading…